| Product NDC: | 59627-002 |
| Proprietary Name: | AVONEX |
| Non Proprietary Name: | interferon beta-1a |
| Active Ingredient(s): | 30 ug/1 & nbsp; interferon beta-1a |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59627-002 |
| Labeler Name: | Biogen Idec MA Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103628 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20030523 |
| Package NDC: | 59627-002-05 |
| Package Description: | 4 INJECTION, SOLUTION in 1 CARTON (59627-002-05) |
| NDC Code | 59627-002-05 |
| Proprietary Name | AVONEX |
| Package Description | 4 INJECTION, SOLUTION in 1 CARTON (59627-002-05) |
| Product NDC | 59627-002 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | interferon beta-1a |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20030523 |
| Marketing Category Name | BLA |
| Labeler Name | Biogen Idec MA Inc. |
| Substance Name | INTERFERON BETA-1A |
| Strength Number | 30 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Interferon-beta [Chemical/Ingredient],Recombinant Human Interferon beta [EPC],Recombinant Proteins [Chemical/Ingredient] |